Effects of Inhibiting Glycoprotein MUC5AC by Seaweed Ecklonia cava Extract in human Airway Epithelial Cells
Authors:
Open Access
- 31 December 2021
- journal article
- research article
- Published by The Korean Society for Biomedical Laboratory Sciences in Biomedical Science Letters
- Vol. 27 (4) , 334-339
Abstract
Sung-Gyu Lee and Sang-Oh Kwon. BSL 2021;27:334-9. https://doi.org/10.15616/BSL.2021.27.4.334Keywords
Funding Information
- Ministry of Oceans and Fisheries
This publication has 19 references indexed in Scilit:
- Induction of apoptosis by phloroglucinol derivative from Ecklonia Cava in MCF-7 human breast cancer cellsFood and Chemical Toxicology, 2009
- Southern Ocean seaweeds: A resource for exploration in food and drugsAquaculture, 2009
- Triphlorethol‐A induces heme oxygenase‐1 via activation of ERK and NF‐E2 related factor 2 transcription factorFEBS Letters, 2007
- An anticoagulative polysaccharide from an enzymatic hydrolysate of Ecklonia cavaCarbohydrate Polymers, 2006
- Treatment of airway mucus hypersecretionAnnals of Medicine, 2006
- Antioxidant activities of enzymatic extracts from brown seaweedsBioresource Technology, 2005
- Triphlorethol-A fromEcklonia cavaprotects V79-4 lung fibroblast against hydrogen peroxide induced cell damageFree Radical Research, 2005
- PMA Induces the MUC5AC Respiratory Mucin in Human Bronchial Epithelial Cells, via PKC, EGF/TGF-α, Ras/Raf, MEK, ERK and Sp1-dependent MechanismsJournal of Molecular Biology, 2004
- Comparison of the free radical-scavenging activity of propolis from several regions of ArgentinaJournal of Ethnopharmacology, 2000
- Asthma in childhoodJournal of Allergy and Clinical Immunology, 1983